Rupatadine: a review of its use in the management of allergic disorders.

Abstract:

:Rupatadine (Rupafin, Rinialer, Rupax, Alergoliber) is a selective oral histamine H(1)-receptor antagonist that has also been shown to have platelet-activating factor (PAF) antagonist activity in vitro. It is indicated for use in seasonal allergic rhinitis (SAR), perennial allergic rhinitis (PAR) and chronic idiopathic urticaria (CIU) in patients aged >/=12 years. Clinical trials show that rupatadine is an effective and generally well tolerated treatment for allergic rhinitis and CIU. It has a rapid onset of action and a prolonged duration of activity. Importantly, it has no significant effect on cognition, psychomotor function or the cardiovascular system. Once-daily rupatadine significantly improves allergic rhinitis symptoms in patients with SAR, PAR or persistent allergic rhinitis (PER) compared with placebo, and provides similar symptom control to that of loratadine, desloratadine, cetirizine or ebastine. In patients with CIU, longer-term use of rupatadine improves CIU symptoms to a greater extent than placebo. It is as well tolerated as other commonly used second-generation H(1)-receptor antagonists. Thus, the introduction of rupatadine extends the range of oral agents available for the treatment of allergic disorders, including allergic rhinitis and CIU.

journal_name

Drugs

journal_title

Drugs

authors

Keam SJ,Plosker GL

doi

10.2165/00003495-200767030-00008

subject

Has Abstract

pub_date

2007-01-01 00:00:00

pages

457-74

issue

3

eissn

0012-6667

issn

1179-1950

pii

6738

journal_volume

67

pub_type

杂志文章,评审

相关文献

DRUGS文献大全
  • Rabeprazole: a review of its use in acid-related gastrointestinal disorders.

    abstract::Rabeprazole is an inhibitor of the gastric proton pump. It causes dose-dependent inhibition of acid secretion and has a more rapid onset of action than omeprazole. Duodenal ulcers healed faster after treatment with rabeprazole 20 or 40 mg/day than placebo or ranitidine 150 mg 4 times daily and at a generally similar r...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.2165/00003495-199958040-00014

    authors: Langtry HD,Markham A

    更新日期:1999-10-01 00:00:00

  • Myocardial infarction. Secondary prevention with nifedipine.

    abstract::The rationale for the use of nifedipine in patients with acute myocardial infarction (MI) is based on the various cardiovascular actions of the compound: reduction of myocardial oxygen consumption by attenuation of cardiac and vascular smooth muscle tension; augmentation of oxygen and substrate supply after increased ...

    journal_title:Drugs

    pub_type: 临床试验,杂志文章,随机对照试验,评审

    doi:10.2165/00003495-199100422-00007

    authors: Rafflenbeul W,Ebner F

    更新日期:1991-01-01 00:00:00

  • Pharmacotherapy for obesity.

    abstract::Pharmacotherapy for the management of obesity is primarily aimed at weight loss, weight loss maintenance and risk reduction, and has included thyroid hormone, amphetamines, phentermine, amfepramone (diethylpropion), phenylpropanolamine, mazindol, fenfluramines and, more recently, sibutramine and orlistat. These agents...

    journal_title:Drugs

    pub_type: 杂志文章,meta分析,评审

    doi:10.2165/00003495-200565100-00006

    authors: Ioannides-Demos LL,Proietto J,McNeil JJ

    更新日期:2005-01-01 00:00:00

  • Premenopausal patients with node-positive resectable breast cancer. Preliminary results of a randomised trial comparing 3 adjuvant regimens: FEC 50 x 6 cycles vs FEC 50 x 3 cycles vs FEC 75 x 3 cycles. The French Adjuvant Study Group.

    abstract::Anthracyclines are among the most active drugs for the treatment of advanced breast cancer. Epirubicin has been found to be as effective as doxorubicin at equimolar doses but significantly better tolerated, especially in terms of alopecia, leucopenia, and cardiac toxicity. The role of anthracycline-containing regimens...

    journal_title:Drugs

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.2165/00003495-199300452-00007

    authors: Fumoleau P,Devaux Y,Vo Van ML,Kerbrat P,Fargeot P,Schraub S,Mihura J,Namer M,Mercier M

    更新日期:1993-01-01 00:00:00

  • Coronary thrombolysis for evolving myocardial infarction.

    abstract::An acute thrombus at the site of an atherosclerotic obstruction is the usual cause of myocardial infarction. Thrombolytic therapy is an exciting new therapy for reducing the extent of myocardial infarction by lysing intracoronary clots. Such therapy has now been widely applied by: prolonged intravenous infusion of str...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.2165/00003495-198428050-00004

    authors: Spann JF,Sherry S

    更新日期:1984-11-01 00:00:00

  • Clinical efficacy of ofloxacin in lower respiratory tract infections. A multicentre study.

    abstract::A multicentre clinical trial was carried out to determine the activity and tolerability of ofloxacin in the treatment of lower respiratory tract infections. 667 patients were randomly allocated to 1 of 3 different twice daily dosage regimens: 400 mg (245 patients), 600 mg (211) or 800 mg (211). The mean duration of tr...

    journal_title:Drugs

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.2165/00003495-198700341-00017

    authors: Grassi C,Gialdroni Grassi G,Mangiarotti P

    更新日期:1987-01-01 00:00:00

  • Antiepileptic drug development in children: considerations for a revisited strategy.

    abstract::The European Commission and the European Parliament have acknowledged the specific need for a proper evaluation of new drugs in children. The evaluation of the antiepileptic drugs (AEDs) available on the market illustrates the deficit in therapeutic trials for childhood epilepsy syndromes. Currently, the development o...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.2165/00003495-200868010-00002

    authors: Chiron C,Dulac O,Pons G

    更新日期:2008-01-01 00:00:00

  • Alitretinoin: A Review in Severe Chronic Hand Eczema.

    abstract::Chronic hand eczema is a common but frequently disabling skin condition which poses a significant social and economic burden. Although skin protection measures and topical therapies are fundamental in its management, some patients are refractory to first-line therapy with topical corticosteroids and require systemic t...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.1007/s40265-016-0621-0

    authors: Blair HA,Scott LJ

    更新日期:2016-09-01 00:00:00

  • Optimizing the use of thrombolytics in ST-segment elevation myocardial infarction.

    abstract::The advent of thrombolytic therapy was a major advance in the treatment of ST-segment elevation myocardial infarction (STEMI). The administration of fibrinolytic reperfusion therapy can reduce mortality rates by as much as 30%, with the greatest benefit observed if therapy is administered soon after symptom onset. Out...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.2165/11317670-000000000-00000

    authors: Morse MA,Todd JW,Stouffer GA

    更新日期:2009-10-01 00:00:00

  • Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future.

    abstract::Coronary artery disease and acute myocardial infarction still represent the leading cause of mortality in developed countries. Therefore, great efforts have been made in the last decades to improve reperfusion strategies and adjunctive antithrombotic therapies. In fact, despite optimal epicardial recanalisation, a lar...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.1007/s40265-015-0425-7

    authors: De Luca G,Savonitto S,van't Hof AW,Suryapranata H

    更新日期:2015-07-01 00:00:00

  • Are All Dopamine Agonists Essentially the Same?

    abstract::Dopamine agonists (DAs) represent an excellent treatment option for patients with Parkinson's disease, in both the early and advanced stages of the disease, improving motor symptoms, lowering the incidence of motor complications, and addressing several non-motor symptoms. Indeed, each of these compounds have different...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.1007/s40265-019-01103-2

    authors: Torti M,Bravi D,Vacca L,Stocchi F

    更新日期:2019-05-01 00:00:00

  • Tocilizumab: a review of its use in the management of rheumatoid arthritis.

    abstract::Tocilizumab (RoActemra or Actemra) is a recombinant humanized monoclonal antibody that acts as an interleukin (IL)-6 receptor antagonist. Intravenous tocilizumab 8 mg/kg (and no less than 4.8 mg), in combination with methotrexate, is approved in the EU for the treatment of moderate to severe active rheumatoid arthriti...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.2165/00003495-200969050-00007

    authors: Oldfield V,Dhillon S,Plosker GL

    更新日期:2009-01-01 00:00:00

  • Pomalidomide: A Review in Relapsed and Refractory Multiple Myeloma.

    abstract::Pomalidomide (Imnovid®; Pomalyst®), an analogue of thalidomide, is an immunomodulatory agent, with several mechanisms of action (both direct and indirect) thought to be involved in its anti-myeloma activity. Oral pomalidomide is available in several countries for use in combination with low-dose dexamethasone in adult...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.1007/s40265-017-0833-y

    authors: Hoy SM

    更新日期:2017-11-01 00:00:00

  • Diquafosol ophthalmic solution 3 %: a review of its use in dry eye.

    abstract::Diquafosol ophthalmic solution 3 % (Diquas(®)) is a P2Y2 receptor agonist that promotes tear fluid and mucin secretion and is currently approved in Japan and South Korea for the treatment of dry eye. In randomized, double-blind, multicentre trials in patients with dry eye, significantly greater improvements in fluores...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.1007/s40265-015-0409-7

    authors: Keating GM

    更新日期:2015-05-01 00:00:00

  • Low molecular weight heparins: a guide to their optimum use in pregnancy.

    abstract::The incidence of pulmonary embolism (PE) and venous thromboembolism (VTE) is higher in pregnant patients than in non-pregnant patients. The incidence of thrombosis in all pregnancies is reported to be between 0.05 and 1%, and an incidence as high as 3% may be present in women after caesarean section. Anticoagulant med...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.2165/00003495-200262030-00004

    authors: Laurent P,Dussarat GV,Bonal J,Jego C,Talard P,Bouchiat C,Cellarier G

    更新日期:2002-01-01 00:00:00

  • The funny current: cellular basis for the control of heart rate.

    abstract::The 'funny' (pacemaker, I(f)) current, first described almost 30 years ago in sinoatrial node (SAN) myocytes, is a mixed sodium/potassium inward current, activated on hyperpolarisation in the diastolic range of voltages. 'Funny' (f) channels are activated by intracellular cyclic adenosine monophosphate (cAMP) concentr...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.2165/00003495-200767002-00003

    authors: DiFrancesco D,Borer JS

    更新日期:2007-01-01 00:00:00

  • Aflibercept: A Review of Its Use in Diabetic Macular Oedema.

    abstract::Aflibercept (Eylea(®)) is an anti-vascular endothelial growth factor agent indicated for intravitreal use in the treatment of diabetic macular oedema. In patients with diabetic macular oedema, significantly greater improvements from baseline to week 52 in visual acuity were seen with intravitreal aflibercept versus ma...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.1007/s40265-015-0421-y

    authors: Keating GM

    更新日期:2015-07-01 00:00:00

  • Inhibitory effects of nedocromil sodium on the in vitro induced migration and leukotriene formation of human granulocytes.

    abstract::Inflammatory cells, such as neutrophils and eosinophils, are thought to actively contribute to the pathogenesis of asthma since they infiltrate into the lung tissue and may be activated locally to release bronchoconstrictor mediators. In this study we provide evidence that nedocromil sodium is capable of effectively i...

    journal_title:Drugs

    pub_type: 杂志文章

    doi:10.2165/00003495-198900371-00004

    authors: Bruijnzeel PL,Warringa RA,Kok PT,Hamelink ML,Kreukniet J

    更新日期:1989-01-01 00:00:00

  • Pharmacologic management of advanced cervical cancer: antiangiogenesis therapy and immunotherapeutic considerations.

    abstract::As a consequence of disparities in access to and utilization of preventative healthcare, the incidence and death rates from cervical cancer remain substantial in the face of indisputable evidence that screening saves lives. While disparities persist, there will be an urgent need for research into the treatment of adva...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.1007/s40265-015-0481-z

    authors: Longoria TC,Tewari KS

    更新日期:2015-11-01 00:00:00

  • Protective effects of calcium antagonists against ischaemia and reperfusion damage.

    abstract::The most positive results in this area have been those of the second Danish Study Group on Verapamil in Myocardial Infarction (1990) which assessed the benefit of treatment with verapamil from the second week after myocardial infarction. Verapamil produced a significant reduction in both mortality and reinfarction rat...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.2165/00003495-199100421-00005

    authors: Ferrari R,Visioli O

    更新日期:1991-01-01 00:00:00

  • Abiraterone acetate: in metastatic castration-resistant prostate cancer.

    abstract::Oral abiraterone acetate, in combination with prednisone/prednisolone, is used to treat patients with metastatic castration-resistant prostate cancer (CRPC) who have previously received docetaxel-containing chemotherapy. Abiraterone acetate was developed to specifically inhibit cytochrome P450 (CYP)17A1, which is an e...

    journal_title:Drugs

    pub_type: 杂志文章

    doi:10.2165/11208080-000000000-00000

    authors: Yang LP

    更新日期:2011-10-22 00:00:00

  • Panic disorder. Pathophysiology and drug treatment.

    abstract::Advances over the past 2 decades in our understanding of the biology of panic disorder have paralleled a remarkable increase in the development of new pharmacological agents with antipanic effects. Although we can not presently use biological tests to help with our choice of therapeutic agent for individual patients, ...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.2165/00003495-199549030-00002

    authors: Johnson MR,Lydiard RB,Ballenger JC

    更新日期:1995-03-01 00:00:00

  • Influence of intensive versus conventional glucose control on microvascular and macrovascular complications in type 1 and 2 diabetes mellitus.

    abstract::In type 1 and 2 diabetes mellitus patients, hyperglycaemia is independently related to the development of microvascular and macrovascular complications. Glycaemic targets and the benefits of intensive versus conventional glucose control are under debate. The purpose of this review is to provide an overview of the rand...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.2165/11585220-000000000-00000

    authors: Mattila TK,de Boer A

    更新日期:2010-12-03 00:00:00

  • Aliskiren/hydrochlorothiazide combination: in mild to moderate hypertension.

    abstract::Aliskiren/hydrochlorothiazide is a single-pill combination of the first in the new class of non-peptide direct renin inhibitors (aliskiren) and a thiazide diuretic (hydrochlorothiazide [HCTZ]) that achieves blood pressure (BP) reductions greater than those seen with either component alone. In double-blind, 8-week clin...

    journal_title:Drugs

    pub_type: 杂志文章

    doi:10.2165/00003495-200969070-00004

    authors: Baldwin CM,Plosker GL

    更新日期:2009-01-01 00:00:00

  • Transdermal Nicotine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as an aid to smoking cessation.

    abstract::Transdermal nicotine delivery systems are a cigarette smoking cessation aid designed to deliver nicotine into the systemic circulation via the skin. The partial replacement of plasma nicotine, which would have otherwise been obtained from cigarettes, reduces the severity of nicotine withdrawal symptoms, and so allows ...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.2165/00003495-199244030-00011

    authors: Palmer KJ,Buckley MM,Faulds D

    更新日期:1992-09-01 00:00:00

  • Cryptococcal infections: changing epidemiology and implications for therapy.

    abstract::Although the incidence of HIV-associated cryptococcosis has decreased in developed countries since the introduction of antiretroviral therapy, this disease continues to cause significant morbidity and mortality in sub-Saharan Africa among patients with AIDS. Important strides have been made in an attempt to decrease t...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.1007/s40265-013-0037-z

    authors: La Hoz RM,Pappas PG

    更新日期:2013-05-01 00:00:00

  • Recent developments in salvage chemotherapy for patients with metastatic soft tissue sarcoma.

    abstract::The number of effective cytotoxic agents for the treatment of patients with metastatic adult soft tissue sarcoma is limited, especially when patients have failed anthracycline- and ifosfamide-based chemotherapy. For the subgroup of patients with inoperable gastrointestinal stromal tumour (GIST), progress has been made...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.2165/00003495-200565020-00002

    authors: Hartmann JT,Patel S

    更新日期:2005-01-01 00:00:00

  • Will abuse-deterrent formulations of opioid analgesics be successful in achieving their purpose?

    abstract::During the last 2 decades, there has been a dramatic increase in the use of strong opioids for chronic non-cancer pain. This increase has been accompanied by a steep increase in abuse, misuse, and both fatal and non-fatal overdoses involving prescription opioids. The situation is already alarming in the US. Prescripti...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.2165/11635860-000000000-00000

    authors: Bannwarth B

    更新日期:2012-09-10 00:00:00

  • Overview of the management of acute gout and the role of adrenocorticotropic hormone.

    abstract::It is important to distinguish between therapy used to reduce acute inflammation in gout and therapy used to manage hyperuricaemia in patients with chronic gouty arthritis. This article discusses treatments for acute gout, emphasizing the use of corticotrophin (adrenocorticotropic hormone; ACTH) and the evidence on wh...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.2165/00003495-200868040-00002

    authors: Schlesinger N

    更新日期:2008-01-01 00:00:00

  • Alfuzosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia.

    abstract::Alfuzosin, a new quinazoline derivative, acts as a selective and competitive antagonist of alpha 1-adrenoceptor-mediated contraction of prostatic, prostatic capsule, bladder base and proximal urethral smooth muscle, thereby reducing the tone of these structures. Consequently, urethral pressure and resistance, bladder ...

    journal_title:Drugs

    pub_type: 杂志文章,评审

    doi:10.2165/00003495-199345030-00008

    authors: Wilde MI,Fitton A,McTavish D

    更新日期:1993-03-01 00:00:00